Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma
Clinical trial NCT04927195 · COMPLETED
Trial details
- NCT number
- NCT04927195
- Sponsor
- Evelo Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-23
- Primary completion
- 2022-02-28
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.